InvestSMART

Beamtree Holdings Limited (ASX:BMT)

ALERT: Price-sensitive ASX Announcement for BMT
Current share price for BMT : $0.105 -0.055 (-34.38%)+
Announcement
Release
19 Feb 2026 8:31AM
Price at Release
$0.160
Full Release
download
Summary
Beamtree Holdings Limited reported a strategic focus on advancing its AI-based healthcare solutions during the first half of FY26. The company highlighted its progress in areas such as clinical decision-making, coding accuracy, and reimbursement improvements through its AI-enabled platforms. Key initiatives included the launch of the Evolve data platform in the UK, trials of the Autonomous Coding Solution (ACS), and the Autonomous Data Entry (ADE) systems. The company experienced an increase in its qualified pipeline and maintained strong demand across Australia, the UK, Europe, Canada, and the Middle East. Beamtree is aiming for double-digit growth in Annual Recurring Revenue (ARR) for FY26. The Board has initiated a strategic review to unlock shareholder value, with plans to simplify its product portfolio and geographic footprint.
Key Points
  • Beamtree targets double-digit FY26 ARR growth.
  • AI solutions are advancing towards commercial deployment.
  • Launch of Evolve platform in the UK and ACS trials.
  • Strong demand in Australia, UK, Europe, Canada, Middle East.
  • Strategic review commenced to enhance shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.